PegBio (2565) Announces Voluntary Dissolution of Shanghai Maiji and Director’s Information Update

Bulletin Express

Nov 04

PegBio Co., Ltd. (the Company, stock code: 2565) announced that on 28 October 2025, an application was filed to voluntarily dissolve its non-wholly-owned subsidiary, Shanghai Maiji Biotech Co., Ltd. (Shanghai Maiji). Established on 26 June 2017, Shanghai Maiji was engaged in the research and development of GLP-2, a peptide hormone involved in intestinal functions and metabolism.

According to a shareholders’ resolution dated 11 October 2025, Shanghai Maiji is being dissolved to allow the Company to focus on its core business and streamline operations. The Company stated that the dissolution is not expected to adversely affect its operations or financial position.

Additionally, in line with the listing rules, updated information was provided regarding Dr. Michael Min XU, who serves as the Chairman, an executive director, and the general manager of the Company, as well as the executive director of Shanghai Maiji. The Company confirmed that no other information needs to be brought to the attention of its shareholders.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1162611094"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1162611094\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1162611094?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-04 00:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162611094","market":"us","top_or_hot":-1,"title":"PegBio (2565) Announces Voluntary Dissolution of Shanghai Maiji and Director’s Information Update","media":"Bulletin Express","content":"<p>PegBio Co., Ltd. (the Company, stock code: 2565) announced that on 28 October 2025, an application was filed to voluntarily dissolve its non-wholly-owned subsidiary, Shanghai Maiji Biotech Co., Ltd. (Shanghai Maiji). Established on 26 June 2017, Shanghai Maiji was engaged in the research and development of GLP-2, a peptide hormone involved in intestinal functions and metabolism.</p>\n<p>According to a shareholders’ resolution dated 11 October 2025, Shanghai Maiji is being dissolved to allow the Company to focus on its core business and streamline operations. The Company stated that the dissolution is not expected to adversely affect its operations or financial position.</p>\n<p>Additionally, in line with the listing rules, updated information was provided regarding Dr. Michael Min XU, who serves as the Chairman, an executive director, and the general manager of the Company, as well as the executive director of Shanghai Maiji. The Company confirmed that no other information needs to be brought to the attention of its shareholders.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PegBio (2565) Announces Voluntary Dissolution of Shanghai Maiji and Director’s Information Update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPegBio (2565) Announces Voluntary Dissolution of Shanghai Maiji and Director’s Information Update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-04 00:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PegBio Co., Ltd. (the Company, stock code: 2565) announced that on 28 October 2025, an application was filed to voluntarily dissolve its non-wholly-owned subsidiary, Shanghai Maiji Biotech Co., Ltd. (Shanghai Maiji). Established on 26 June 2017, Shanghai Maiji was engaged in the research and development of GLP-2, a peptide hormone involved in intestinal functions and metabolism.</p>\n<p>According to a shareholders’ resolution dated 11 October 2025, Shanghai Maiji is being dissolved to allow the Company to focus on its core business and streamline operations. The Company stated that the dissolution is not expected to adversely affect its operations or financial position.</p>\n<p>Additionally, in line with the listing rules, updated information was provided regarding Dr. Michael Min XU, who serves as the Chairman, an executive director, and the general manager of the Company, as well as the executive director of Shanghai Maiji. The Company confirmed that no other information needs to be brought to the attention of its shareholders.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02565","symbol_name":"派格生物医药-B","start_time":0,"source_url":"","article_id":"1162611094","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162611094","pubTimestamp":1762187668,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"PegBio Co., Ltd. (the Company, stock code: 2565) announced that on 28 October 2025, an application was filed to voluntarily dissolve its non-wholly-owned subsidiary, Shanghai Maiji Biotech Co., Ltd....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02565":"派格生物医药-B"},"translate_title":"培格生物(2565)公布自愿解散上海麦积及董事资料更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02565":1},"content_text":"PegBio Co., Ltd. (the Company, stock code: 2565) announced that on 28 October 2025, an application was filed to voluntarily dissolve its non-wholly-owned subsidiary, Shanghai Maiji Biotech Co., Ltd. (Shanghai Maiji). Established on 26 June 2017, Shanghai Maiji was engaged in the research and development of GLP-2, a peptide hormone involved in intestinal functions and metabolism.\nAccording to a shareholders’ resolution dated 11 October 2025, Shanghai Maiji is being dissolved to allow the Company to focus on its core business and streamline operations. The Company stated that the dissolution is not expected to adversely affect its operations or financial position.\nAdditionally, in line with the listing rules, updated information was provided regarding Dr. Michael Min XU, who serves as the Chairman, an executive director, and the general manager of the Company, as well as the executive director of Shanghai Maiji. The Company confirmed that no other information needs to be brought to the attention of its shareholders.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}